Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Feds, States Diverge on Medical Marijuana
April 24, 2006

Email
Email
Print
Print
SubscribeSubscribe
News Summary

State officials say a new statement from the U.S. Food and Drug Administration (FDA) denying that marijuana has medical uses won't affect state laws legalizing medical-marijuana use, the New York Times reported April 22.

Nathan Barankin, a spokesman for California attorney general Bill Lockyer, said the FDA statement is "consistent with the long-held federal view on this medicine, and that is that marijuana is the equivalent of heroin and cocaine. California voters disagree."

He added: "There's sort of a détente. Both sides respect that we have laws that differ. Federal law-enforcement agencies for the most part have shown some respect for California law by only going after those individuals who seem to be clearly not in the medical-marijuana business for the medical part of it -- which are the same people the state law is going after."

"Really, there's nothing that's going to happen -- any third parties judging whether these substances are effective -- that is going to change Maine law," added Maine assistant attorney general James M. Cameron; Maine passed a medical-marijuana law in 1999.

A spokesperson for the U.S. Drug Enforcement Administration (DEA) said the statement helped clarify the position of the federal government and its intention to enforcement the laws against marijuana use.

Medical-marijuana advocates said the FDA statement could make it harder to pass medical-use laws in states like Connecticut, New Jersey, and New Mexico, which are currently considering such legislation. A recent U.S. Supreme Court ruling that federal marijuana laws could be enforced even in states with medical-marijuana laws had a similar chilling effect.

"We're going to have members of state legislatures say, 'But even the FDA has said there's no medical value,' " said Ethan Nadelmann, executive director of the Drug Policy Alliance. "That's where it's going to hurt."

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, focused, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post personal requests for help or general promotions for your organization (Get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.